Participated · Equity · May 2026

Vi offers a suite of AI agents integrated with its Activate, Engage, and Operate applications that recommend next steps for patients, physicians, and operational teams. The agents draw on Vi’s Data Web, which aggregates clinical signals, behavioral data, and operational metrics to enable real-time decisions across patient care navigation, physician decision support, clinical trial acceleration, and drug commercialization. Vi serves more than 100 enterprise customers in healthcare and life sciences, has supported the commercialization of 50 drugs, and reports coverage of 190 million lives. The company estimates its platform has generated $2 billion in measurable value for customers. Following a $145 million funding round at a $1.64 billion valuation, Vi plans to hire and retain talent, expand its platform, develop new products, and strengthen its balance sheet.